Authors
Loading...
Provides alternate tetraselenafulvalene route; leaves open comparative yield or scalability advantages.
Key points are not available for this paper at this time.
Lakshmikantham et al. (1976) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: